During the past decade, Kindai University Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 5 clinical trials were completed, i.e. on average, 17.9% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 1 clinical trials were completed. i.e. 4.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kindai University Hospital" #1 sponsor was "Amgen" with 6 trials, followed by "Pfizer" with 6 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Biogen" with 2 trials sponsored and "Daiichi Sankyo, Inc." with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kindai University Hospital" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Kindai University Hospital" are "Marginal Zone Lymphoma" (3 trials), "Solid Tumors" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Gastric Cancer" (2 trials) and "Gastroesophageal Junction Adenocarcinoma" (2 trials). Many other conditions were trialed in "Kindai University Hospital" in a lesser frequency.

Most popular intervention types in "Kindai University Hospital" are "Drug" (33 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Bemarituzumab" (3 trials), "Rituximab" (3 trials), "Cisplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kindai University Hospital" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kindai University Hospital". undefined are not yet recruiting, 11 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Kindai University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kindai University Hospital, 6 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".